LabPulse.com

Molecular diagnostics company Co-Diagnostics is to receive over $2 million from the Bill & Melinda Gates Foundation toward completion of tuberculosis (TB) and human papillomavirus (HPV) tests for the company's Co-Dx PCR Home platform.

Co-Diagnostics awarded over $2M from Bill & Melinda Gates Foundation for TB and HPV tests Dwight Egan, CEO of Co-Diagnostics, said the grants would help support the worldwide effort to prevent the spread of both TB and HPV in countries where they have been endemic killers for generations.

The Association for Molecular Pathology (AMP) and other bodies have published recommendations on the inclusion of additional alleles in clinical pharmacogenomic (PGx) genotyping assays.

Molecular pathology bodies recommend expansion of pharmacogenomic test panels In its latest project, the working group investigated clinical CYP3A4 and CYP3A5 PGx testing, leading the AMP and its collaborators to issue consensus recommendations on the genes.

An analysis of 462 million lipid test results has shown mean total cholesterol levels exceed the target in seven of the 17 studied countries.

Analysis of 462M lipid test results reveals global variation in cholesterol levels Mean total cholesterol levels exceeded the World Health Organization (WHO) target in seven of the 17 countries included in the analysis, namely Japan, Australia, North Macedonia, Switzerland, Germany, Slovakia, and Austria.